Trimethoprim-sulfamethoxazole prophylaxis for pneumocystis carinii infections in heart-lung and lung transplantation—how effective and for how long?

Transplantation

Volumn 53, Issue 3, 1992, Pages 586-589

  Kramer, Mordechai R ^a,b   Stoehr, Christopher ^a   Lewiston, Norman J ^a,b   Starnes, Vaughn A ^a,b   Theodore, James ^a  

^a Department of Pediatrics   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; ARTICLE; CHILD; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RATE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROPHYLAXIS;

ADRENAL CORTEX HORMONES; ADULT; CHILD, PRESCHOOL; DRUG TOLERANCE; HEART-LUNG TRANSPLANTATION; HUMAN; IMMUNE TOLERANCE; INFANT; LUNG TRANSPLANTATION; PNEUMONIA, PNEUMOCYSTIS CARINII; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0026609234     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199203000-00019     Document Type: Article

References (21)

1. Dummer JS. Pneumocystis carinii infections in transplant recipi- ents. Semin Respir Infect 1990; 1: 50.
2. Dummer JS. Infection complication of transplantation. In: Thomp-son ME, ed. Cardiac transplantation. Philadelphia: F. A. Davis, 1990: 163.
3. Austin JHM, Shulman LL, Mastobatista JD. Pulmonary infection after cardiac transplantation: clinical and radiological correla-tions. Radiology 1989; 172: 259.
4. Gryzan S, Paradis IL, Zeevi A, et al. Unexpected high incidence of Pneumocystis carinii infection after heart-lung transplantation. Am Rev Respir Dis 1988; 137: 1268.
5. Brooks RG, Hofflin JM, Gamison SW, et al. Infection complica-tions in heart-lung transplant recipients. Am J Med 1985; 79: 412.
6. Penketh AR, Higenbottam TW, Hutter J, Coutts C, Stewart S, Wallwark J. Clinical experience in the management of pulmonary opportunistic infection and rejection in recipients of heart-lung transplants. Thorax 1988; 43: 762.
7. Starnes VA, Theodore J, Oyer P, et al. Evaluation of heart-lung transplant recipients with prospective serial transbronchial biop-sies and pulmonary function studies. J Thorac Cardiovasc Surg 1989; 98: 683.
8. Hardey A, Wasjaszxuk CP, Sufferdini AF, Hakala TR, Ho M. Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporine and prednisone. J Infect Dis 1984; 149: 143.
9. Kusne S, Dummer JS, Singh N, et al. Infections after liver trans-plantation: an analysis of 101 consecutive cases. Medicine 1988; 67: 32.
10. Cordonnier C, Bernaudin JF, Bierling P, Huet Y, Vernant JP. Pulmonary complications occurring after allogeneic bone marrow transplantation: a study of consecutive 130 transplant patients. Cancer 1986; 58: 10-47.
11. Higenbottam T, Jackson M, Woolman P, Lowery R, Wallwork J. The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. Am Rev Respir Dis 1989; 140: 58.
12. Shankar S, Foulsham L, Aravot D, Read RC, Madden B. Mucoci-liary function after lung transplantation. Transplant Proc 1991; 23: 12-22.
13. Walzer PD. Experimental models of Pneumocystis carinii infec-tions. In: Young LS, ed. Pneumocystis carinii pneumonia. New York: Dekker, 1984: 7.
14. Hofflin JM, Potasman I, Baldwin JC, et al. Infectious complica-tions in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1975; 106: 209.
15. Hughes W, Kuhn S, Chaudhary S, et al. Successful chemoprophy-laxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297: 1419.
16. Hughes W, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987; 316: 1627.
17. Masur H, Lane C, Kovacks JA, Allegra CJ, Edman JC. Pneumo-cystis carinii pneumonia. Ann Intern Med 1989: 111: 813.
18. Montgomery BA. Prophylaxis for Pneumocystis carinii pneumonia in patients with infected with human immune deficiency virus type 1. Semin Respir Infect 1989; 4: 311.
19. Davey R, Masur H. Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 1990; 34: 499.
20. Centers for Disease Control. Guidelines for prophylaxis agents against Pneumocystis carinii pneumonia in persons infected with human immune deficiency virus. MMWR 1989; 38: 5.
21. Higgins RM, Bloom SL, Hopkin JM, et al. The risk and benefits of low dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in renal transplantation. Transplantation 1989; 47: 558.